Unlicensed and off label drug use for paediatric patients. Optimal dosing schedules with gentamicin are needed for premature neonates
Conroy, S.
Bmj 317(7152): 204-205
1998
ISSN/ISBN: 0959-8138 PMID: 9705639 Document Number: 492832
Document emailed within 1 workday
Related Documents
Martin, R.M.; Wilton, L.V.; Mann, R.D.; Steventon, P.; Hilton, S.R. 1998: Unlicensed and off label drug use for paediatric patients. General practitioners prescribe SSRIs to children off label Bmj 317(7152): 204Bavdekar, S.B.; Gogtay, N.J. 2005: Unlicensed and off-label drug use in children Journal of Postgraduate Medicine 51(4): 249-252
Bavdekar, S.B.; Gogtay, N.J. 2005: Unlicensed and off-label drug use in children Journal of Postgraduate Medicine 51(4): 249-252
Kiatchoosakun, P.; Kosalaraksa, P.; Jirapradittha, J.; Taksaphan, S.; Tassniyom, S. 2005: Once-daily gentamicin dosing of 4 Mg/Kg/dose in neonates Journal of the Medical Association of Thailand 88(7): 934-938
Kanthawatana, S.; Uruwannakul, K.; Chotinarumon, S. 1998: Gentamicin pharmacokinetics in Thai neonates: recommendation for a dosing guideline Journal of the Medical Association of Thailand 81(2): 136-140
Tshefu, A.; Lokangaka, A.; Ngaima, S.; Engmann, C.; Esamai, F.; Gisore, P.; Ayede, A.I.; Falade, A.G.; Adejuyigbe, E.A.; Anyabolu, C.H.; Wammanda, R.D.; Ejembi, C.L.; Ogala, W.N.; Gram, L.; Cousens, S. 2015: Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial Lancet 385(9979): 1758-1766
Tshefu, A.; Lokangaka, A.; Engmann, C.; Esamai, F.; Gisore, P.; Ayede, A.I.; Falade, A.G.; Adejuyigbe, E.A.; Anyabolu, H.; Wammanda, R.D.; Ogala, W.N.; Gram, L.; Cousens, S.; Bahl, R.; Rollins, N.; Yoshida, S.; Qazi, S.A. 2013: Treatment of fast breathing in neonates and young infants with oral amoxicillin compared with penicillin-gentamicin combination: study protocol for a randomized, open-label equivalence trial Pediatric Infectious Disease Journal 32(Suppl 1): S33-S38
Tshefu, A.; Lokangaka, A.; Ngaima, S.; Engmann, C.; Esamai, F.; Gisore, P.; Ayede, A.I.; Falade, A.G.; Adejuyigbe, E.A.; Anyabolu, C.H.; Wammanda, R.D.; Ejembi, C.L.; Ogala, W.N.; Gram, L.; Cousens, S. 2015: Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial Lancet 385(9979): 1767-1776
Regazzi, B.M.; Rondanelli, R.; Dionigi, R.V.; Mapelli, A.; Gasati, A. 1986: Dosing problems of gentamicin in critically ill patients International Journal of Clinical Pharmacology Research 6(5): 355-359
Hurkacz, M.; Nowakowska, J.M.; Paluszyńska, D.; Królak-Olejnik, B. 2019: Individualization of treatment with gentamicin in neonates based on drug concentration in the blood serum Developmental Period Medicine 23(1): 21-27
Chetchotisakd, P.; Anunnatsiri, S.; Wankun, J.; Mootsikapun, P.; Boonyaprawit, P. 2002: A randomized, open-label, comparative trial of BID and TID dosing of saquinavir enhanced oral formulation as part of a triple therapy for advanced AIDS patients Journal of the Medical Association of Thailand 85(5): 590-596
Tsavaris, N.; Kosmas, C.H.; Vadiaka, M.; Kontos, A.; Katsorida, M.; Dimitrakopoulos, A.; Zerai, A.; Koufos, C.H. 2001: Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. a randomized study Journal of Experimental and Clinical Cancer Research: Cr 20(1): 29-34
Howard, P.; Copland, J. 2013: Off-label, not off-limits: the FDA needs to create a safe harbor for off-label drug use Missouri Medicine 110(2): 106-109
Mukonzo, J.K. 2014: The challenge of paediatric efavirenz dosing: implications and way forward for the sub-Saharan Africa Aids 28(13): 1855-1857
Kosalaraksa, P.; Janthep, P.; Jirapradittha, J.; Taksaphan, S.; Kiatchoosakun, P. 2004: Once versus twice daily dose of gentamicin therapy in Thai neonates Journal of the Medical Association of Thailand 87(4): 372-376
Eshelman, F.N.; Snodgrass, G.L. 1976: Comparative levels of gentamicin in infants and neonates. A literature review and discussion American Journal of Pharmacy and the Sciences Supporting Public Health 148(2): 53-58
Kuo, B.; Castell, D.O. 1996: Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls American Journal of Gastroenterology 91(8): 1532-1538
Fagrell, B.; Riddez, L. 2009: Change of law concerning drug trials is needed: Sweden should allow testing in unconscious patients Lakartidningen 106(48): 3217-3218
Thijs, L.; Fagard, R.; Lijnen, P.; Staessen, J.; Van Hoof, R.; Amery, A. 1994: Why is antihypertensive drug therapy needed in elderly patients with systolodiastolic hypertension? Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(6): S25-S34
O'Brien, A.J.; Fenelon, L.E.; O'Dwyer, R.; McCann, S.R.; Daly, P.A. 1988: A comparative study of latamoxef disodium and gentamicin versus piperacillin and gentamicin in febrile granulocytopenic patients British Journal of Clinical Practice 42(2): 56-60